Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
China · Delayed Price · Currency is CNY 29.33
+1.88 (6.85%)
At close: Aug 4, 2026
SHA:688163 Market Cap
SHA:688163 has a market cap or net worth of 2.97 billion as of August 4, 2026. Its market cap has increased by 12.22% in one year.
Market Cap
2.97B
Enterprise Value
2.21B
Revenue
197.68M
Ranking
n/a
PE Ratio
51.26
Stock Price
29.33
ChartMarket Cap Chart
Since March 11, 2022, SHA:688163's market cap has decreased from 5.98B to 2.97B, a decrease of -50.36%. That is a compound annual growth rate of -14.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 2.97B | 26.09% |
| Dec 31, 2025 | 2.36B | 23.97% |
| Dec 31, 2024 | 1.90B | -12.16% |
| Dec 29, 2023 | 2.16B | -5.22% |
| Dec 30, 2022 | 2.28B | -61.86% |
| Mar 11, 2022 | 5.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Obio Technology (Group) Corp. | 3.48B |
| Shanghai Shen Lian Biomedical | 3.42B |
| Lifecome Biochemistry | 3.34B |
| Jiangsu Bioperfectus Technologies | 3.25B |
| Hinova Pharmaceuticals | 3.24B |
| Baolingbao Biology | 3.05B |
| Zhejiang Shouxiangu Pharmaceutical | 2.94B |
| Guanhao Biotech | 2.94B |